174 related articles for article (PubMed ID: 12528311)
1. Caspases and neuroprotection.
Bilsland J; Harper S
Curr Opin Investig Drugs; 2002 Dec; 3(12):1745-52. PubMed ID: 12528311
[TBL] [Abstract][Full Text] [Related]
2. Survivin: a target from brain cancer to neurodegenerative disease.
Baratchi S; Kanwar RK; Kanwar JR
Crit Rev Biochem Mol Biol; 2010 Dec; 45(6):535-54. PubMed ID: 20925597
[TBL] [Abstract][Full Text] [Related]
3. [Cell death protection by anti-apoptotic factor].
Takahashi R
Rinsho Shinkeigaku; 2001 Dec; 41(12):1067-9. PubMed ID: 12235797
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic potential of AIF-mediated caspase-independent programmed cell death.
Lorenzo HK; Susin SA
Drug Resist Updat; 2007 Dec; 10(6):235-55. PubMed ID: 18180198
[TBL] [Abstract][Full Text] [Related]
5. The combination of isoflurane and caspase 8 inhibition results in sustained neuroprotection in rats subject to focal cerebral ischemia.
Inoue S; Davis DP; Drummond JC; Cole DJ; Patel PM
Anesth Analg; 2006 May; 102(5):1548-55. PubMed ID: 16632840
[TBL] [Abstract][Full Text] [Related]
6. Prolonged therapeutic window for ischemic brain damage caused by delayed caspase activation.
Fink K; Zhu J; Namura S; Shimizu-Sasamata M; Endres M; Ma J; Dalkara T; Yuan J; Moskowitz MA
J Cereb Blood Flow Metab; 1998 Oct; 18(10):1071-6. PubMed ID: 9778183
[TBL] [Abstract][Full Text] [Related]
7. Prospects for antiapoptotic drug therapy of neurodegenerative diseases.
Waldmeier PC
Prog Neuropsychopharmacol Biol Psychiatry; 2003 Apr; 27(2):303-21. PubMed ID: 12657369
[TBL] [Abstract][Full Text] [Related]
8. Recent clinical failures in Parkinson's disease with apoptosis inhibitors underline the need for a paradigm shift in drug discovery for neurodegenerative diseases.
Waldmeier P; Bozyczko-Coyne D; Williams M; Vaught JL
Biochem Pharmacol; 2006 Nov; 72(10):1197-206. PubMed ID: 16901468
[TBL] [Abstract][Full Text] [Related]
9. Caspase requirement for neuronal apoptosis and neurodegeneration.
Nicotera P
IUBMB Life; 2000 May; 49(5):421-5. PubMed ID: 10902574
[TBL] [Abstract][Full Text] [Related]
10. Caspase inhibition after neonatal ischemia in the rat brain.
Joly LM; Mucignat V; Mariani J; Plotkine M; Charriaut-Marlangue C
J Cereb Blood Flow Metab; 2004 Jan; 24(1):124-31. PubMed ID: 14688624
[TBL] [Abstract][Full Text] [Related]
11. Neuroprotection in progressive brain disorders.
Djaldetti R; Lev N; Melamed E
Isr Med Assoc J; 2003 Aug; 5(8):576-80. PubMed ID: 12929297
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of calpain and caspase-3 prevented apoptosis and preserved electrophysiological properties of voltage-gated and ligand-gated ion channels in rat primary cortical neurons exposed to glutamate.
Ray SK; Karmakar S; Nowak MW; Banik NL
Neuroscience; 2006 May; 139(2):577-95. PubMed ID: 16504408
[TBL] [Abstract][Full Text] [Related]
13. Astrocyte apoptosis: implications for neuroprotection.
Takuma K; Baba A; Matsuda T
Prog Neurobiol; 2004 Feb; 72(2):111-27. PubMed ID: 15063528
[TBL] [Abstract][Full Text] [Related]
14. PPAR: a new pharmacological target for neuroprotection in stroke and neurodegenerative diseases.
Bordet R; Ouk T; Petrault O; Gelé P; Gautier S; Laprais M; Deplanque D; Duriez P; Staels B; Fruchart JC; Bastide M
Biochem Soc Trans; 2006 Dec; 34(Pt 6):1341-6. PubMed ID: 17073815
[TBL] [Abstract][Full Text] [Related]
15. Apoptosis in neuronal development and transplantation: role of caspases and trophic factors.
Boonman Z; Isacson O
Exp Neurol; 1999 Mar; 156(1):1-15. PubMed ID: 10192773
[TBL] [Abstract][Full Text] [Related]
16. Neuroprotective efficacy of the peroxisome proliferator-activated receptor delta-selective agonists in vitro and in vivo.
Iwashita A; Muramatsu Y; Yamazaki T; Muramoto M; Kita Y; Yamazaki S; Mihara K; Moriguchi A; Matsuoka N
J Pharmacol Exp Ther; 2007 Mar; 320(3):1087-96. PubMed ID: 17167170
[TBL] [Abstract][Full Text] [Related]
17. 3-[2-[4-(3-Chloro-2-methylphenylmethyl)-1-piperazinyl]ethyl]-5,6-dimethoxy-1-(4-imidazolylmethyl)-1H-indazole dihydro-chloride 3.5 hydrate (DY-9760e) is neuroprotective in rat microsphere embolism: role of the cross-talk between calpain and caspase-3 through calpastatin.
Han F; Shirasaki Y; Fukunaga K
J Pharmacol Exp Ther; 2006 May; 317(2):529-36. PubMed ID: 16467455
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological inhibition of mitochondrial membrane permeabilization for neuroprotection.
Hisatomi T; Ishibashi T; Miller JW; Kroemer G
Exp Neurol; 2009 Aug; 218(2):347-52. PubMed ID: 19303007
[TBL] [Abstract][Full Text] [Related]
19. Neuroprotective effects of caspase-3 inhibition on functional recovery and tissue sparing after acute spinal cord injury.
Citron BA; Arnold PM; Haynes NG; Ameenuddin S; Farooque M; Santacruz K; Festoff BW
Spine (Phila Pa 1976); 2008 Oct; 33(21):2269-77. PubMed ID: 18827691
[TBL] [Abstract][Full Text] [Related]
20. A tetracycline-regulated adenovirus encoding dominant-negative caspase-9 is regulated in rat brain and protects against neurotoxin-induced cell death in vitro, but not in vivo.
Ebert AD; Chen F; He X; Cryns VL; Bohn MC
Exp Neurol; 2005 Feb; 191 Suppl 1():S80-94. PubMed ID: 15629764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
